articleHere, EPR explores some highlights of the UK’s new Life…
30 August 2021 | By Hannah Balfour (European Pharmaceutical Review)
Here, EPR explores some highlights of the UK’s new Life Sciences Vision for the pharma, biopharma and biotech industries, covering topics from funding to regulatory reviews and clinical trial innovation.